Select Page
FDA Essure Monitoring Shows Even Worse Side Effects

FDA Essure Monitoring Shows Even Worse Side Effects

On December 31, 2018, the FDA removed Essure from the market. This decision follows the agency’s April safety action of restricting sales and distribution. Previously, the United States was the only country that still allowed women to get the device. Every other...

Dangerous Injuries of Firefighting Foam

For decades, firefighters including those stationed at military bases and airports used chemical-based foam due to effectiveness in extinguishing jet fuel and petroleum fires. Known as aqueous film-forming foam (AFFF), manufacturers make this product with the toxic...

Drug Manufacturers Exaggerate Medication Benefits

The FDA has established a Bad Ads program to review promotional materials from drug manufacturers. This includes TV, radio, sales aids, journal ads, patient brochures, drug websites, webinars, email alerts, and e-details. Since starting the program, the agency has...
Singulair Linked to Increased Suicide

Singulair Linked to Increased Suicide

Due to the increased risk of suicide while taking the popular asthma medication, Singulair, the FDA added the strongest warning to medication in March of this year.  The agency received countless reports of potential psychiatric side effects for years before adding...
×
What Our Clients Are Saying